250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical VC (Venture Capital) Funds in Germany in January 2025

A list of 50 VC (Venture Capital) funds that invest in Medical startups based in Germany. We rank investors based on the number of investments they made in Medical companies from Germany. We update this investor list every month.

Top 50 Medical VC (Venture Capital) Funds in Germany in January 2025

Investor Medical Germany investments
HTGF | High-Tech Gruenderfonds 18
KfW 12
Bayern Kapital 11
MIG Capital 7
NRW.BANK 7
BioMedPartners 7
Wellington Partners 7
b2venture 6
Calm/Storm Ventures 5
bm-t beteiligungsmanagement thuringen 5
TGFS - Technologiegründerfonds Sachsen 5
IBB Ventures 5
HV Capital 5
Picus Capital 5
Possible Ventures 5
Rheingau Founders 4
EQT Life Sciences 4
Brandenburg Kapital 4
Atlantic Labs 4
seed + speed Ventures 4
UNIQA Ventures 3
Sparkasse Jena 3
SOSV 3
LSP BioVentures 3
Born2Grow 3
Boehringer Ingelheim Venture Fund 3
BayBG Venture Capital 3
Global Asset Fund 3
DvH Ventures 3
Vorwerk Ventures 3
VI Partners 3
Forbion Capital Partners 3
Playground Global 3
Bertelsmann Investments 3
Vesalius Biocapital Partners 3
WestTech Ventures 3
SV Investment Corp 2
Global Life Science Ventures 2
WEGVISOR 2
Antler 2
Springboard Health Angels 2
Wachstumsfonds Bayern 2
Groupe Arnault 2
DocCheck Guano AG 2
Entrée Capital 2
Sofinnova Partners 2
APEX Ventures 2
KHAN Technology Transfer Fund 2
Winning Mindset Ventures 2
Cherry Ventures 2
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
HTGF | High-Tech Gruenderfonds VC Fund · Bonn, Nordrhein-Westfalen, Germany · 60 investments in the past 12 months
The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.
Show more
Investment focus
  • Software, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • Germany, Switzerland, United States
Portfolio highlights
  • Pagent — Pagent develops AI systems.
  • Refoxy Pharma — Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.
  • Lindis Blood Care — Lindis Blood Care´s mission is to optimise the outcome of cancer surgeries by developing a Medical Device to remove cancer cells from blood during cancer surgeries to enable Autologous Blood Transfusion.
KfW VC Fund · Frankfurt, Hessen, Germany
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more
Investment focus
  • Biotechnology, Software, Health Care
  • Funding Round, Series A, Series B
  • Germany, India, Kenya
Portfolio highlights
  • Uniper — Uniper is an international energy company with about 11,000 employees. They combine a balanced portfolio of technologically advanced large-scale assets with outstanding technical and commercial expertise. Uniper is a German energy company based in Dusseldorf, North Rhine-Westphalia. It was formed by the separation of E.ON's fossil fuel assetsinto a separate company that began operating on 1 January 2016.
  • Vectoflow — Vectoflow is an innovative company developing fluid-dynamic metrology devices for fluid flow and dynamics measurement. It offers standardized and customized flow measurement technology that measures the static and total pressure, velocity, and angle of attack of a flow. These products are used in motorsport, aviation, turbine machine development,and research sectors.
  • Electrochaea — Electrochaea is commercializing a disruptive, scalable technology to convert electric power into methane, the principal component of natural gas. Using CO2 as a feedstock gas, power can be efficiently converted to renewable natural gas for power storage, for transportation fuels, or for transmission via a natural gas network. The company licensedtechnology from the University of Chicago and is led by the Nidus Partners, a St. Louis investment group specializing in renewable energy. Mich Hein, a Nidus Managing Partner, serves as CEO.Electrochaea has developed a commercially viable and disruptive solution for utility-scale energy storage, grid balancing, and carbon reuse. Their proprietary process converts low-cost and stranded electricity and carbon dioxide into pipeline-grade renewable gas for direct injection into the existing natural gas grid, a conversion process known as “power-to-gas”.
Bayern Kapital VC Fund · Landshut, Bayern, Germany · 23 investments in the past 12 months
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Series A, Funding Round
  • Germany, United States, Finland
Portfolio highlights
  • Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
  • Loyalift — Loyalift unlocks the power of "hidden" consumer data through AI-driven analytics, combine it with customer internal data and enables brand to take strategic decisions in the most efficient way. With an annual video marketing spend of €144 billion lacking in effectiveness tracking, Loyalift addresses the critical gap in understandingconsumer interactions and brand perception in digital spaces. Our innovative AI platform not only analyzes video content (both live and saved) but also provides contextual insights into user interactions, offering brands a unique tool for measuring call-to-actions, brand perception, and market desires.Our solution enables seamless integration of customer data from CRM & ERP systems with Loyalift's insights, facilitating direct communication through a sophisticated AI model. This integration empowers brands to make strategic decisions based on a holistic view of market feedback and internal data analytics. Loyalift's vision is to transform customer relationships by consolidating diverse data endpoints, guiding brands toward informed strategic decisions and enhanced market positioning. Experience the future of market analytics with Loyalift, where every piece of data tells a story.
  • StrategyBridgeAI — Automated data-driven analyses for any company out there. Our users include: Private equity, corporate strategy, M&A advisors & consultants.
MIG Capital VC Fund · München, Bayern, Germany · 4 investments in the past 12 months
Zusammen gestalten wir die Unternehmen von morgen.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Funding Round, Series B
  • Germany, France, Austria
Portfolio highlights
  • Inbolt — InBolt has developed the world’s smallest and most efficient 3D camera tracking system. Their first product is a hardware module / device that an operator can plug onto all manual tools such as a drill, a screwdriver or a torque wrench. Once on the tool, it guides the operator, validates the completion of a task in real time and registers allthe completion parameters.
  • SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
  • Innatera — Innatera is a Dutch nanotech company and an offspring of the Delft University of Technology in the Netherlands.
NRW.BANK VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 4 investments in the past 12 months
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more
Investment focus
  • Biotechnology, Software, Information Technology
  • Seed, Series A, Series B
  • Germany, United States, United Kingdom
Portfolio highlights
  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • Black Semiconductor — Black Semiconductor manufacture microchips with integrated electronic-photonic circuits using graphene technology.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
BioMedPartners VC Fund · Basel, Basel-Stadt, Switzerland · 2 investments in the past 12 months
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • Switzerland, Germany, France
Portfolio highlights
  • ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
  • TOLREMO therapeutics — TOLREMO therapeutics is striving to prevent the development of cancer therapy resistance through its proprietary drug discovery and development platform. Learn more about us.
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
Wellington Partners VC Fund · Munich, Bayern, Germany · 9 investments in the past 12 months
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more
Investment focus
  • Health Care, Biotechnology, Medical
  • Series A, Series B, Funding Round
  • Germany, United States, United Kingdom
Portfolio highlights
  • Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
  • CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.
b2venture VC Fund · Saint Gallen, Sankt Gallen, Switzerland · 13 investments in the past 12 months
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more
Investment focus
  • Software, Health Care, Artificial Intelligence
  • Series A, Seed, Series B
  • Germany, Switzerland, United Kingdom
Portfolio highlights
  • 1Komma5° — KOMMA5 ° offers all owners of electric vehicles free electricity, which we refinance through trading with so-called GHG quotas. 1KOMMA5 ° encourages to lead a self-determined and CO2-neutral life.
  • Predium — Predium is the software platform for real estate owners to measure, manage and communicate their ESG performance.
  • Quanta — OG Home description
Calm/Storm Ventures VC Fund · Vienna, Wien, Austria · 10 investments in the past 12 months
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more
Investment focus
  • Health Care, Wellness, Software
  • Seed, Pre-Seed, Series A
  • Germany, United Kingdom, Austria
Portfolio highlights
  • PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
  • Linq — The safest way to send intimate content
  • Univa Health — Univa's objective is to provide evidence-based clinical tools that address the detrimental impact of eating disorder diseases on both the individual and their families.
bm-t beteiligungsmanagement thuringen VC Fund · Erfurt, Thuringen, Germany
bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Seed, Funding Round, Series A
  • Germany, United States
Portfolio highlights
  • rooom — rooom is a global startup based in Germany, launched in 2019. The company’s experienceCloud is an all-in-one platform for creating, managing and promoting engaging 2D, 3D, AR & VR experiences. It works across all desktop and mobile devices. rooom’s experienceCloud is designed to cover the marketing and visualization needs of differentindustries through their comprehensive product portfolio. These include eventCloud (optimized for virtual events, exhibitions, conferences, meetings), spaceCloud (real estate, property, museums), productCloud (3D products, product showrooms) and immerseCloud (tours, guides, 3D books). rooom’s eventCloud is routinely hosting up to 200,000 users for hybrid events like IFA, Berlin and for global customers such as Porsche, Deutsche Telekom, DHL and E.ON. rooom has won over 20 awards, including the Global Eventex Award (twice), the Innovation & Excellence Award and the German Innovation Award.
  • Enginsight — Enginsight GmbH was founded in August 2017. With a highly motivated team, they are working together on the vision of providing companies with a solution that will enable them to safely and confidently navigate the digital future. Enginsight helps leading companies autonomously monitor and secure their entire IT landscape. Certified and highlytrained employees form the heart of Enginsight, together with partner companies around the globe. They analyze and monitor complete IT landscapes – recognize the connections and dependencies between websites and servers up to IoT-devices. The innovative software platform acts autonomously and points out the critical paths, risks and threats.
  • Coachwhisperer — Coachwhisperer: The live communication system for sports. We take training to the next level and help coaches and athletes reach their true potential.
TGFS - Technologiegründerfonds Sachsen VC Fund · Leipzig, Sachsen, Germany · 6 investments in the past 12 months
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more
Investment focus
  • Software, Information Technology, Manufacturing
  • Seed, Series A, Funding Round
  • Germany, United States
Portfolio highlights
  • In.hub — in.hub is a specialist in condition monitoring of machines, processes, and products, offering digitalisation options in the industrial environment. It connects legacy and modern systems, creates condition monitoring systems, and generates information for optimal planning and control.
  • Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
  • Zenesis — Zenesis intends to change the way engineering planning processes are carried out.
IBB Ventures VC Fund · Berlin, Berlin, Germany · 16 investments in the past 12 months
IBB Ventures is a venture capital and mezzanine arm of Investitionsbank Berlin specializing in seed/startup, early venture, and mid venture investments. The firm invests in technology-oriented companies and companies from the creative industries. It typically invests in information and communication sector with a focus on hardware andsoftware, network technology, new media, and internet and mobile technologies; life science sector with a focus on biotechnology and media technology; and industrial technologies sector with a focus on software, PPS, supply chain management, micro and nanotechnology, environmental and power technology, automation, manufacturing technology, transport technology and logistics, and new materials. The firm also invests in movies, broadcast, television, publisher, music, entertainment, advertising, fashion, design, architecture, multimedia, games, software, and art and culture. It invests in companies based in Berlin. It typically invests between €0.25 million ($0.32 million) and €3 million ($3.83 million) per transaction. The firm prefers to take a board seat in its portfolio companies. IBB Ventures was founded in 1997 and is based in Berlin, Germany.
Show more
Investment focus
  • Software, Health Care, Internet
  • Seed, Funding Round, Series A
  • Germany, United States, United Kingdom
Portfolio highlights
  • Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
  • Meine Erde — Meine Erde is a provider of ecological burial option in Europe.
  • ARC Intelligence — ARC Intelligence operates as a supplier of data systems driven by AI for small and medium-sized businesses.
HV Capital VC Fund · Munich, Bayern, Germany · 21 investments in the past 12 months
We support exceptional founders in building market leading digital companies.
Show more
Investment focus
  • E-Commerce, Internet, Software
  • Series A, Seed, Series B
  • Germany, United Kingdom, United States
Portfolio highlights
  • KoRo — KoRo is a fast-growing FoodTech startup - one of the leading brands for healthy, long-lasting and sustainable food.
  • Tourlane — Tourlane is a booking platform for multi-day tours, offering amazing experiences to over 30 countries worldwide. It creates adventures and authentic travel experiences to fabulous destinations in the world.The company combines the first-hand experience of a travel agency with the simplicity of an online product. Its apps bring travel consultancyto a state-of-the-art level of tech and design and thereby will shape the future of individual and adventure trips. Its product matches travelers with pre-selected travel specialists, making the booking of individual and adventure trips comparable, fast, and easy.
  • Upvest — Upvest empowers financial institutions to offer investment products in their app with a modular, scalable, and accessible API. Upvest brings together everything that’s required to offer a broad range of investment products on the website and app. They are connected to the world’s leading asset providers and exchanges to provide the bestinvestments, at the best prices and execution speed.
Picus Capital VC Fund · Munich, Bayern, Germany · 24 investments in the past 12 months
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more
Investment focus
  • Financial Services, Software, FinTech
  • Seed, Series A, Pre-Seed
  • Germany, United States, United Kingdom
Portfolio highlights
  • Omni HR — Omni HR helps companies automate the end-to-end employee journey including onboarding, time off, employee management, and more. Easy to use and customizable!
  • Prima — Reliable manufacturing & supply chain partner for custom parts, metal fabrication & efficient sourcing from Mexico. Manage design, production & delivery
  • Spot My Energy — The uptake of PV, EVs, home storage, and heat pumps leads to a gigantic need for digital and intelligent metering and for the integration of millions of...
Possible Ventures VC Fund · Munich, Bayern, Germany · 9 investments in the past 12 months
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more
Investment focus
  • Software, Information Technology, Biotechnology
  • Seed, Pre-Seed, Series A
  • Germany, Australia, United States
Portfolio highlights
  • tozero — Truly bringing lithium-ion battery waste tozero by recovering all critical matierlas, like lithium, nickel, cobalt, manganese, and graphite.
  • HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
  • Hippos Exoskeleton — Hippos Exoskeleton created an auto-inflating knee brace to avoid tears in the ACL and other injuries.
Rheingau Founders VC Fund · Berlin, Berlin, Germany
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more
Investment focus
  • Software, E-Commerce, Internet
  • Seed, Series A, Pre-Seed
  • Germany, United States, Poland
Portfolio highlights
  • MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
  • Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
  • Akhetonics — Creating the first all-optical RISC Processor
EQT Life Sciences VC Fund · Amsterdam, Noord-Holland, The Netherlands · 10 investments in the past 12 months
EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, The Netherlands, Switzerland
Portfolio highlights
  • PanTera — PanTera wants to bring a new hope to cancer patients by enabling the widespread use of radiopharmaceuticals for personalised treatment of tumors
  • ATB Therapeutics — ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
  • Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
Brandenburg Kapital VC Fund · Potsdam, Brandenburg, Germany · 6 investments in the past 12 months
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more
Investment focus
  • Information Technology, Software, Health Care
  • Seed, Series A, Funding Round
  • Germany, United Kingdom
Portfolio highlights
  • Mateo — Mateo is the omni-channel customer experience powerhouse that empowers local brands and businesses to drive growth through a digital customer lifecycle management. From acquiring new leads, converting them into customers and extending those relationships - all in one platform.
  • family.cards — Family.cards provides elders with barrier-free access to digital solutions and all the tools they need to manage their circumstances.
  • Sphingotec GmbH — Improving patient outcomes with innovative diagnostics for critical care: Actionable insights in real-time
Atlantic Labs VC Fund · Berlin, Berlin, Germany · 10 investments in the past 12 months
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures.&nbsp;<br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Seed, Pre-Seed, Series A
  • Germany, Switzerland, United States
Portfolio highlights
  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • Mago — Mago is an AI-native, fully controllable tool revolutionizing video production through style transfer. We empower creators to transform and stylize any video - from live-action to 3D animations - into any aesthetic, seamlessly blending cutting-edge AI with human creativity from concept to final cut.
  • LEVY Health — Endometriosis is a condition where tissue like your uterine lining grows outside the womb: on the ovaries, fallopian tubes, pelvic tissues, or more rarely, in other parts of the body.
seed + speed Ventures VC Fund · Berlin, Berlin, Germany · 3 investments in the past 12 months
Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more
Investment focus
  • Software, SaaS, Health Care
  • Seed, Pre-Seed, Series A
  • Germany, Austria, Switzerland
Portfolio highlights
  • Briink — Our AI helps private equity firms and companies automate and scale their EU Taxonomy and SFDR assessments. Get in touch today.
  • mogenius — mogenius radically simplifies cloud infrastructure for software developers. The code to cloud platform provides a completely automated workflow of deploying an application in Kubernetes - with hyperscale cloud resources, built-in CI/CD and DDoS protection so you can start coding in seconds. Never waste time on complicated, error-prone, andrepetitive configurations in your cloud infrastructure again, and focus on what you really love: building great applications.
  • Enginsight — Enginsight GmbH was founded in August 2017. With a highly motivated team, they are working together on the vision of providing companies with a solution that will enable them to safely and confidently navigate the digital future. Enginsight helps leading companies autonomously monitor and secure their entire IT landscape. Certified and highlytrained employees form the heart of Enginsight, together with partner companies around the globe. They analyze and monitor complete IT landscapes – recognize the connections and dependencies between websites and servers up to IoT-devices. The innovative software platform acts autonomously and points out the critical paths, risks and threats.
UNIQA Ventures VC Fund · Vienna, Wien, Austria · 2 investments in the past 12 months
UNIQA Ventures GmbH is the Venture Capital arm of UNIQA Insurance Group AG, a leading insurance carrier in Central & Eastern Europe and a pioneer in Corporate-backed Venture Capital in Austria and CEE. Based in Vienna, Austria, the firm is investing in outstanding business models driven by strong teams and a clear vision to shape the future ofkey industries. Investment areas are the future of Health, Mobility, Intelligent Home and FinTech/InsurTech as well as enabling technologies such as IoT, Blockchain, ML/AI.
Show more
Investment focus
  • Insurance, Health Care, FinTech
  • Series A, Seed, Series B
  • Austria, Germany, United Kingdom
Portfolio highlights
  • ifeel — Ifeel is the emotional well-being platform for modern organizations. Ifeel is a unique workplace mental health platform for companies.
  • GoUrban — goUrban offers mobility solutions for sharing operators and B2B fleet management. The way of transportation and mobility is changing rapidly. For operating smarter and using the opportunities of the sharing economy we provide you our fleet management OS.
  • doctorly — doctorly is a digital medical infrastructure platform. We have a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools & workflows directly with our doctors & patients.We are backedby amazing investors and driven by a desire to make positive and meaningful changes to the healthcare industry internationally.
Sparkasse Jena VC Fund · Jena, Thuringen, Germany
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more
Investment focus
  • Medical, Shopping, E-Commerce
  • Seed, Series A, Series C
  • Germany, United States
Portfolio highlights
  • ShopCo Technologies — Shop uses Artificial Intelligence to empower online shopping experience for customers. It is a universal shopping cart browser extension that keeps all the items of its users across the web in one spot. Stores can be registered online and without any hassle. It helps its users browse through a wide range of online stores and checkout from one spot.The company gives ability to connect to all its users existing retailer accounts. It also secures data with encryption methods and two-step verifications. Shop is a U.S.-based company that was founded in 2014 by Jay Habib.
  • NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
  • Dynamic42 — Dy­nam­ic42 provides, customizes innovative 3D mi­cro­phys­i­o­log­i­cal in vit­ro test systems recre­at­ing human organ key functions. It develops and markets novel, three-dimensional, human organ models (scalloped organ-on-chip technology) for pre­clin­i­cal research and developmental, as well as for testing novel pharmaceutical products,chemicals, and food additives. It is specialized in the area of organ-on-chip technology in the integration of the immune system, which plays a significant role in the occurrence of adverse effects of drugs and has been neglected in the industry and in two-dimensional test systems.
SOSV VC Fund · Princeton, New Jersey, United States · 75 investments in the past 12 months
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
  • Biotechnology, Health Care, Software
  • Seed, Convertible Note, Pre-Seed
  • United States, India, United Kingdom
Portfolio highlights
  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
LSP BioVentures VC Fund · Cambridge, Massachusetts, United States
LSP BioVentures is a venture capital fund focused on opportunities in the life science arena. Based in Cambridge (MA) in the USA; the fund’s management combines the strength of its parent company, Life Sciences Partners Venture Capital firm in Europe and a dedicated team of experts in the USA.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Series C
  • United States, Germany, United Kingdom
Portfolio highlights
  • Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
  • Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
  • HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
Born2Grow VC Fund · Heilbronn, Baden-Wurttemberg, Germany
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more
Investment focus
  • Software, Health Care, Medical
  • Seed, Series A, Series B
  • Germany, Finland, United States
Portfolio highlights
  • Semorai — Semorai - Engineering AI
  • Doinstruct — Doinstruct offers mobile training solution for frontline workers.
  • traplinked — Digitale Fallensysteme - Endlich wissen, was los ist! Mit den traplinked Sensormodulen JERRY und TOM erhalten Sie in Echtzeit ein digitales Abbild Ihrer Kontrollpunkte.
Boehringer Ingelheim Venture Fund VC Fund · Ingelheim Am Rhein, Rheinland-Pfalz, Germany · 2 investments in the past 12 months
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
  • Biotechnology, Health Care, Therapeutics
  • Series A, Series B, Seed
  • United States, Germany, Belgium
Portfolio highlights
  • Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
  • Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
  • Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
BayBG Venture Capital VC Fund · München, Bayern, Germany
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more
Investment focus
  • Software, Information Technology, Health Care
  • Funding Round, Series A, Series B
  • Germany, Italy, United States
Portfolio highlights
  • memtime — memtime shows you everything you worked on during the day. Each program is recorded so that you can quickly remember. Add-on available for any software. | memtime
  • StoryBox — StoryBox provides a Software as a Service solution for businesses to create, share and structure video content to make it searchable. With the system, companies can create and organize smartphone-based videos for any application scenario. Using the app, videos can be created and shared by every employee using templates. The app suggests picturesettings and scene lengths automatically and offers an automated creation which includes corporate design. The content can be stored in the DSGVO-compliant StoryBox cloud and can be accessed, filtered and analyzed from anywhere. Customers include Iveco, Erste Group, Evonik, Alten, and KTM.
  • Kloster Kitchen — Kloster Kitchen is a monastery kitchen as the root of unique taste.
Global Asset Fund VC Fund · Landshut, Bayern, Germany
Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.
Show more
Investment focus
  • Medical, Therapeutics, Biotechnology
  • Series A, Series B, Funding Round
  • Germany
Portfolio highlights
  • Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
  • Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
DvH Ventures VC Fund · Köln, Nordrhein-Westfalen, Germany · 2 investments in the past 12 months
Investing early in Europe's most passionate founders.
Show more
Investment focus
  • Health Care, Financial Services, Software
  • Seed, Series A, Funding Round
  • Germany, Austria, United Kingdom
Portfolio highlights
  • LiveEO — LiveEO is the leading solution provider for AI-powered satellite-based monitoring of large infrastructure networks. Trusted worldwide.
  • OneTwenty — OneTwenty is an early-stage health tech start-up that develops multiple Machine Learning based solutions for people with diabetes as well as Medtech companies for sensor optimization, biomarker prediction, glucoregulatory models, and iAGC (interoperable automated glycemic controller). Our solution demonstrates unprecedented precision in bloodglucose prediction 120 minutes in advance. OneTwenty revolutionizes the life of people with Type 1 diabetes.
  • HealthCaters — HealthCaters is a connected care solution for companies that allows them to empower their employees to take control of their health.
Vorwerk Ventures VC Fund · Berlin, Berlin, Germany · 7 investments in the past 12 months
Backing early-stage startups that drive positive impact for people and planet
Show more
Investment focus
  • E-Commerce, Health Care, Food and Beverage
  • Seed, Series A, Series B
  • Germany, United Kingdom, Denmark
Portfolio highlights
  • Descycle — Descycle e-waste recycling clean technology
  • CoCoach — CoCoach concentrated on developing a feature-rich web platform specifically for health coaches.
  • Spot My Energy — The uptake of PV, EVs, home storage, and heat pumps leads to a gigantic need for digital and intelligent metering and for the integration of millions of...
VI Partners VC Fund · Altendorf, Schwyz, Switzerland · 3 investments in the past 12 months
VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series A, Series B, Series C
  • Switzerland, Germany, United States
Portfolio highlights
  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
  • LeaseTeq — LeaseTeq bietet Privat- sowie Unternehmenskunden das erste komplett digitale Leasingangebot.
  • Unique — Unlock the power of generative AI in Finance with Unique FinanceGPT. Get custom use cases and accurate insights in a secure, enterprise-ready platform.
Forbion Capital Partners VC Fund · Naarden, Noord-Holland, The Netherlands · 21 investments in the past 12 months
Impacting the future of medicine.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • United States, United Kingdom, The Netherlands
Portfolio highlights
  • Numab — Numab Therapeutics AG
  • Verdiva Bio — Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
  • Orbis Medicines — Orbis Medicines is a novel macrocyclic chemistry and computational platform for high-throughput drug discovery.
Playground Global VC Fund · Palo Alto, California, United States · 4 investments in the past 12 months
Playground is an early-stage investment firm that helps old and new investors and entrepreneurs working at the intersection of bits, atoms, and AI. It focuses on investment, innovation, connected hardware, artificial intelligence, and robotics.
Show more
Investment focus
  • Software, Robotics, Artificial Intelligence
  • Series A, Seed, Series B
  • United States, Canada, France
Portfolio highlights
  • Anjuna — Anjuna confidential cloud software establishes a secure enclave that isolates and encrypts applications and data in runtime, at rest, and on the network for end-to-end data protection
  • Insamo — Insamo is a global biotechnology company pioneering the discovery of membrane-permeable and orally available cyclic-peptides with antibody-like binding affinity.
  • Outpace Bio — Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety.It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacyand safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.
Bertelsmann Investments VC Fund · Gütersloh, Nordrhein-Westfalen, Germany · 3 investments in the past 12 months
The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.
Show more
Investment focus
  • Health Care, Artificial Intelligence, Medical
  • Series B, Series A, Seed
  • Germany, Israel, Malaysia
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • Doccla — We are a start-up. However, our management and advisors combine 100 years of experience in service delivery to large public and private healthcare operators in six European states, as well as several years in wearable device implementation in the global consumer space.
  • Guardoc Health — Streamlining clinical compliance with AI-driven accuracy in charting to meet regulations, enhance patient care, and optimize revenue management.
Vesalius Biocapital Partners VC Fund · Strassen, Luxembourg, Luxembourg · 5 investments in the past 12 months
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series B, Series A, Series C
  • Belgium, Germany, The Netherlands
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
  • Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
WestTech Ventures VC Fund · Berlin, Berlin, Germany
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more
Investment focus
  • Software, Internet, Information Technology
  • Seed, Series A, Funding Round
  • Germany, United States, France
Portfolio highlights
  • Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
  • Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
  • ClimateChoice — The software platform for decarbonizing companies and their supply chains.
SV Investment Corp VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 12 investments in the past 12 months
SV Investment Corp is a venture capital firm that provides companies with finance, strategic advice and information at critical stages of their development.
Show more
Investment focus
  • Software, Information Technology, Artificial Intelligence
  • Series A, Series B, Seed
  • South Korea, United States, Germany
Portfolio highlights
  • Poen — Poen is a venture company of hyundai motors that focuses on battery upcycling using technology.
  • Hopae — On A Journey To Universal Trust. Finally implement a practical Decentralized Identity Solution.
  • Pyler — Filer is an artificial intelligence Martech startup.
Global Life Science Ventures VC Fund · München, Bayern, Germany
Global Life Science Ventures (GLSV) was a venture capital fund focusing exclusively on the life sciences. GLSV was dedicated to supporting early-stage groups, originating from universities, scientific institutions or industry. The fund also invested in selected later stage companies, including buy-outs. For this purpose, GLSV provided finance,advice and access to expertise and networks. The group advised and managed funds totaling more than € 200 million. With offices in Germany and Switzerland, GLSV acted as one team with a global perspective. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series C, Series A, Series B
  • United States, Germany, Denmark
Portfolio highlights
  • Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÐMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
  • Coapt Systems — Coapt Systems, Inc. engages in the design, development, manufacture, and marketing of bio-absorbable implants for use in soft tissue fixation during facial cosmetic surgery procedures. It offers ENDOTINE Forehead 3.0, a bioabsorbable brow fixation device; ENDOTINE Forehead Instrument Kits that comprise insertion tools, drill bits, and sterilizationtrays with lids; ENDOTINE Triple 3.0, the bioabsorbable brow fixation devices with disposable drill bits and insertion tools; ENDOTINE TransBleph 3.0, a bioabsorbable upper lid and brow fixation devices. The company also provides ENDOTINE Midface ST 4.5, a bioabsorbable midface suspension devices; ENDOTINE Ribbon, a bioabsorbable fixation devices; Coapt Manual Surgical Drills, the manual surgical hand drills for use with ENDOTINE implants; and SurgiWire Incisionless Dissectors, the subcutaneous The Endotine product line was bought by MicroAire, a surgical device manufacturer in Charlottesville, VA, in August 2010.
  • Santaris Pharma — Spearheading RNA molecule research since 2003, our site in Copenhagen is focused on leading chemistry for targeting any type of transcribed RNA using short synthetic single-strand oligonucleotides. Here, our experts in the field pioneered our core technology platform of locked nucleic acids (LNA) and antisense oligonucleotides (ASO).
WEGVISOR VC Fund
We effectively support start-ups through early-stage capital, network, know-how, follow-up financing and personality development.
Show more
Investment focus
  • Manufacturing, Medical, Internet
  • Seed, Pre-Seed, Convertible Note
  • Germany
Portfolio highlights
  • BDK Group — Autoglas der Zukunft
  • Infrasolid — Innovative infrared sources for gas detection & spectroscopy. Infrasolid's infrared radiation sources are based on a patented nanotechnology in combination with the self-supporting monolithic structure.
  • Suburban Seafood — Premium producer of shrimp larvae and prawns.
Antler VC Fund · Singapore, Central Region, Singapore · 114 investments in the past 12 months
Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Pre-Seed, Seed, Series A
  • Singapore, United Kingdom, Australia
Portfolio highlights
  • Immibot — Get assistance from our AI-powered chatbot on your immigration journey. Our model is trained on official regulations to answer any questions you may have on how to move abroad.
  • Quench.ai — Quench is a tech infrastructure for video creators to deliver exclusive content, engage and reward their true fans.
  • Source — Source is an AI-powered recruitment platform that makes tech talent sourcing fast, precise, and cost-effective.
Springboard Health Angels VC Fund · Berlin, Berlin, Germany
Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups
Show more
Investment focus
  • Health Care, Software, Biotechnology
  • Seed, Pre-Seed, Funding Round
  • Germany, United States, Sweden
Portfolio highlights
  • deepeye — 66% of blindness in Europe and the US is caused by retinal diseases - and thus preventable.
  • Vivalyx — Vivalyx Omnisol will be a process- and cost-effective one-stop solution for all preservation applications, allowing NMP without the use of blood or human products.
  • PharmaCCX — Welcome to CCX - digital tools purposely-built for market access. Explore our 4 transformative tools, and industry-leading expertise.
Wachstumsfonds Bayern VC Fund · München, Bayern, Germany
Wachstumsfonds Bayern is a venture capital fund that provides equity capital for growth financing to SMEs.It serves private venture capital companies as a neutral co-investment partner for growth financing. The fund's financing enables innovative start-ups to receive more and larger funding, helping them take further growth steps, such asentering new sales markets. It is open to open to innovative, technology, and growth-oriented companies in all industries, regardless of whether external investors are already involved. A general requirement for participation by the BWachstumsfonds Bayern is that the technology company has a successful business model, has successfully completed the seed phase, and the first startup phase and wants to expand. The successfully completed seed and first startup phase may have been financed by external investors or by the founder/cash flow.The firm was founded in München, Bayern.
Show more
Investment focus
  • Medical, Biotechnology, Software
  • Series B, Funding Round, Series A
  • Germany
Portfolio highlights
  • enmacc — enmacc is Europe’s fastest growing digital, OTC energy trading platform. Our platform digitalises the end-to-end professional energy trading process. Using enmacc allows participants to gain speed, efficiency and security when trading in energy markets. More than 340 companies, with over 1.600 active traders, are already taking advantage of enmaccand are utilising our continuously growing network of energy suppliers, industrial companies, energy trading houses and municipal utilities for trading in power & gas. All of our clients can benefit from increased market access, additional liquidity and other business development opportunities. enmacc customers can use three different trading screens: entender (sales trading) & entender pro (professional trading) – the world-leading Request-For-Quote (RFQ) technology for energy markets; enmarket – the OTC price screen and marketplace for one-click trading; and engreen – the state-of-the-art trading screen for Guarantees of Origin (GoOs). Complete documentation and audit-proof archiving of all trading activities on the platform take place automatically. The real-time credit check guarantees secure trading and processes for all participants. Complete documentation and audit-proof archiving of all trading activities on the platform take place automatically. The real-time credit check guarantees secure trading and processes for all participants. We do everything we can to make the daily work of energy traders and portfolio managers easier by enabling them to focus on the things that really matter.
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.
Groupe Arnault VC Fund · Paris, Ile-de-France, France
Groupe Arnault SAS is a principal investment firm. The firm seeks to hold stake in companies and is owned and controlled by Mr. Bernard Arnault. Groupe Arnault SAS was founded in 1978 and is based in Paris, France.
Show more
Investment focus
  • Internet, E-Commerce, Health Care
  • Series C, Series A, Series B
  • United States, Germany, France
Portfolio highlights
  • CarThera — Revolutionizing severe brain disease treatments
  • Ledger — Secure your crypto assets such as Bitcoin, Ethereum, XRP, Monero and more. Give yourself peace of mind by knowing that your cryptocurrencies are safe
  • Open — Live and On Demand mindfulness classes to help you be present, together.
DocCheck Guano AG VC Fund · Cologne, Nordrhein-Westfalen, Germany
Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.
Show more
Investment focus
  • Health Care, Medical Device, Mobile Apps
  • Seed, Funding Round, Pre-Seed
  • Germany, Spain, The Netherlands
Portfolio highlights
  • Amparo — We empower amputees so they can live life to the full. Amparo is a developer, manufacturer and distributor of prosthetic components. It developed the Confidence Socket, which is the interface between the patient's residual limb and the prosthetic leg itself. 1) The fitting process is as fast as 1h time; 2) The material can be remolded 10times, saving huge costs of health providers; and 3) All tools fit into a sports bag. making it possible to service amputee anywhere in the world.
  • medflex — medflex offers secure medical communication via messaging, video calls, and video consultation services.
  • Mammoth Hunters — Mammoth Hunters is a 360° wellness solution offering accessible functional training, natural nutrition and lifestyle advice packaged as a mobile/web based SaaS. The founders come from a scientific background and use discoveries in human physiology and evolution to create personalized fitness journeys. The program is designed toeliminate all barriers that prevent people from leading a healthy lifestyle - lack of time, knowledge and motivation. The company employs 12+ people in Barcelona Spain and has key partnerships with fitness experts, healthcare companies, and sports technology companies.
Entrée Capital VC Fund · London, England, United Kingdom · 13 investments in the past 12 months
We're a team of former serial founders managing over $1.25B across a number of funds, with offices in Tel Aviv, London, and New York.
Show more
Investment focus
  • Software, FinTech, Financial Services
  • Seed, Series A, Series B
  • Israel, United States, United Kingdom
Portfolio highlights
  • Obligo — Rid yourself from the burden of security deposits and go deposit-free. Landlords paid instantly on claims, while tenants repay in installments.
  • PointFive — PointFive provides ongoing cloud cost savings by providing deeper detection and collaborative repair solutions that fit smoothly into teams' normal operations.
  • Archy — SaaS Practice Management Software for Dental Practices
Sofinnova Partners VC Fund · Paris, Ile-de-France, France · 17 investments in the past 12 months
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Series B, Series C
  • France, United States, United Kingdom
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • Genespire — Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases, particularly primary immunodeficiencies and inherited metabolic diseases.
  • Micropep Technologies — Micropep Technologies developes a non-GMO new generation of bioherbicides and biostimulants. Micropep, founded in 2016 in Toulouse, focuses on bioherbicides and biostimulants. The company uses plants’ natural molecules, called “micro-peptides”, to temporarily control expression of their genes and regulate plant growth but leaving their DNA intact.The company currently works on four development programs: germination, flowering, growth, and weed control.
APEX Ventures VC Fund · Vienna, Wien, Austria
APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.
Show more
Investment focus
  • Software, Artificial Intelligence, Health Care
  • Seed, Series A, Pre-Seed
  • Germany, Austria, United Kingdom
Portfolio highlights
  • sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
  • Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
  • Zetta Genomics — At Zetta Genomics our products and services are empowering the application of genomic data to improve health outcomes for millions of patients around the world.
KHAN Technology Transfer Fund VC Fund · Dortmund, Nordrhein-Westfalen, Germany
KHAN Technology Transfer Fund operates as an investment firm.
Show more
Investment focus
  • Medical, Therapeutics, Biotechnology
  • Seed, Series A
  • Germany, Czech Republic, United Kingdom
Portfolio highlights
  • Nodus Oncology — Nodus Oncology Developing the DDR targeting therapies.
  • Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
  • Qli5 Therapeutics — Qli5 Therapeutics develops a new class of proteasome inhibitors with high selectivity and unique, non-covalent binding properties.
Winning Mindset Ventures VC Fund · Gräfelfing, Bayern, Germany · 2 investments in the past 12 months
Startseite von Winning Mindset Ventures
Show more
Investment focus
  • Medical, Software, Consulting
  • Series A
  • Germany
Portfolio highlights
  • deepc — The Radiology AI Platform - Your effortless access to AI
  • XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
Cherry Ventures VC Fund · Berlin, Berlin, Germany · 22 investments in the past 12 months
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more
Investment focus
  • Software, Information Technology, Financial Services
  • Seed, Series A, Series B
  • Germany, United Kingdom, United States
Portfolio highlights
  • Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
  • Courtyard — Turn your trading cards, sneakers, watches, and more into tradable Connected Collectibles and earn a percentage of all future sales.
  • OASYS NOW — The new Standard for Securely Storing and Exchanging Genomic Data. Unlock global data silos and monetize your data pool through OASYS NOW secure enclaves.
Investors by industry
Investors by country
VC (Venture Capital) Funds in Germany by industry